Researchers from the NDCN have used data from UK Biobank participants to reveal that diabetes, traffic-related air pollution and alcohol intake are the most harmful out of 15 modifiable risk factors for dementia.
The Cognitive Neurology Research Group at the Nuffield Department of Clinical Neurosciences has shown that remote digital cognitive testing can detect subtle cognitive impairments in chronic autoimmune limbic encephalitis (ALE) patients.
Research led by scientists at the Universities of Oxford, Cambridge, Copenhagen, Bristol and California (Berkeley) reveals the evolutionary origins of multiple sclerosis (MS). This new insight into the genetic architecture of this disease changes scientists\u2019 view of its causes and has implications for its treatment, as well as paving the way for further investigations into other diseases.
Researchers from the MRC Brain Network Dynamics Unit and Oxford University's Department of Computer Science have set out a new principle to explain how the brain adjusts connections between neurons during learning.
Our researchers have shown for the first time non-invasively in humans a differential, clinically meaningful impact of Huntington\u2019s and Parkinson\u2019s diseases on the sensorimotor functional connection of the subthalamic nucleus and sensorimotor cortex.
Winners of the Medical Research Foundation's second Festive Science Image Competition, run in partnership with the Medical Research Council (MRC), have been announced today.
Research carried out at the University of Oxford has led to the development of a new blood-based test to identify the pathology that triggers Parkinson\u2019s disease before the main symptoms occur. This could allow clinicians to screen for those individuals at high risk of developing the disease and facilitate the timely introduction of precision therapies that are currently at clinical trial stage.
A team of researchers from the University of Oxford has shown for the first time that it is possible to track the progression of Parkinson\u2019s Disease accurately using specially trained machine learning algorithms to analyse data derived from sensor devices worn by patients.
Our researchers have shown the potential of a new gene therapy approach to silence human sensory neurons as a means of treating persistent pain. Many current drugs for chronic pain are highly addictive, which makes it important to discover new alternatives.
PAINCAST: Neuropathic Pain Unravelled, a creative podcast about living with long-term pain, is part of a ground-breaking four-year collaborative research project into neuropathic pain.
![\"Karolien](\"https://www.ndcn.ox.ac.uk/news/oxford-parkinson2019s-disease-centre-open-day-2024-1/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n